This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Nottingham. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: The Innovations of Nigel Halliday
Introduction
Nigel Halliday is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biomedical research, particularly in the detection of infections caused by Pseudomonas aeruginosa. His work has implications for improving patient outcomes through early diagnosis and treatment.
Latest Patents
Nigel Halliday holds a patent titled "Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof." This patent describes a method for determining the infection status of a subject by analyzing a sample of material obtained from them. The method involves measuring the levels of alkyl quinolones or their metabolites produced by Pseudomonas aeruginosa or related species in the sample. He has 1 patent to his name.
Career Highlights
Halliday is affiliated with the University of Nottingham, where he conducts research and collaborates with other experts in the field. His work has been instrumental in advancing the understanding of bacterial infections and their biomarkers.
Collaborations
Some of his notable coworkers include Miguel Camara and Paul Williams. Their collaborative efforts contribute to the ongoing research and development in the area of infectious diseases.
Conclusion
Nigel Halliday's innovative work in the field of infection biomarkers showcases the importance of research in improving healthcare. His contributions are vital for the advancement of diagnostic methods and patient care.